Business Context and Reporting Period
Company: Kewaunee Scientific Corporation
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and nine months ended January 31, 2006
Business Overview: The Company manufactures laboratory furniture and equipment. As of January 5, 2006, there were 2,492,270 shares of Common Stock outstanding.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Jan 31, 2006 | 9 Months Ended Jan 31, 2006 |
|---|---|---|
| Net Sales | $17,724 | $60,351 |
| Gross Profit | $2,446 | $9,317 |
| Gross Margin | 13.8% | 15.4% |
| Operating Earnings (Loss) | $(633) | $365 |
| Net Earnings (Loss) | $(555) | $447 |
| Diluted EPS | $(0.22) | $0.18 |
| Cash from Operations (9mo) | $1,094 | |
| Short-term Borrowings | $6,244 | |
| Working Capital | $11,511 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 13% for the quarter and 11% for the nine-month period compared to the prior year.
- Profitability: The Company recorded a net loss of $555,000 for the quarter, an improvement from the $742,000 loss in the prior year quarter. For the nine months, net earnings were $447,000, compared to a loss of $441,000 in the prior year.
- Unusual Items: Nine-month results included a significant non-operating gain of $884,000 (after-tax gain of $540,000) from the sale of the Company's former plant site in Lockhart, Texas.
- Margin Pressure: Gross margins for the nine months declined to 15.4% from 16.5% in the prior year. This was unfavorably impacted by a $230,000 cost related to a subcontractor failure on a large project and a $205,000 increase in energy costs.
- Expense Management: Operating expenses as a percentage of sales decreased due to flat total expenses against higher sales volume. Bad debt expense declined significantly ($452,000 reduction for the nine months).
- Liquidity: Working capital increased to $11.5 million from $10.4 million at the end of the prior fiscal year. Cash and cash equivalents rose to $890,000 from $225,000.
Outlook, Risks, and Management Commentary
- Order Backlog: The order backlog stood at $35.5 million as of January 31, 2006, a slight increase from $35.2 million at the start of the quarter but down from $41.7 million a year ago.
- Outlook: Management states that the ability to predict future demand is "very limited" due to the Company's role as a subcontractor and dependence on the number of laboratory construction projects.
- Capital Resources: The Company believes current sources of liquidity (operations and a revolving credit facility) are sufficient to support ongoing requirements. $2,756,000 remains available under the revolving credit line.
- Risks: Forward-looking statements are subject to economic, competitive, and governmental factors. Specific risks include the volatility of the construction market and reliance on dealers/subcontractors.
- Pension Plans: No further benefits are being earned under defined benefit plans as of April 30, 2005, and no contributions were expected for the remainder of the fiscal year.
Investor Verification Checklist
- Quality of Earnings: Verify the sustainability of the nine-month profit, which was heavily influenced by a one-time $884,000 gain from the sale of the Lockhart, Texas property.
- Margin Trends: Monitor the impact of the $230,000 subcontractor cost and rising energy costs on future gross margins.
- Inventory Levels: Review the significant increase in inventory ($2.997 million cash outflow), driven by a $700,000 order in transit and increased raw material purchases from offshore vendors.
- Debt Utilization: Assess the utilization of the revolving credit facility, which increased to $6.244 million, leaving $2.756 million available.
- Backlog Stability: Track the order backlog, which has declined year-over-year despite recent sales growth.